Cannabis
 

March 26, 2019

 
 
Top cannabis news from The Globe
 
Edible cannabis in the spotlight as Halifax children’s hospital deals with flood of calls to poison line
Edible cannabis in the spotlight as Halifax children’s hospital deals with flood of calls to poison line
Atlantic Canada’s largest children’s hospital is warning parents about the risks of edible weed after a flood of cannabis-related calls to its poison centre.

 
The IWK Health Centre says it fielded three times as many cannabis calls to its poison line last year than in 2015.

 
The Halifax hospital says poison centres across the country have reported increased weed exposures since recreational pot was legalized last October, most notably with concentrated cannabis products and weed-infused food, especially in kids 12 and under.

 
It says edibles look like the snacks kids love, and children can’t tell the difference between a brownie and a brownie with cannabis.

 
 
Full Story
 
Space is scarce in Okanagan’s cannabis boom
Space is scarce in Okanagan’s cannabis boom
 

ADAM BISBY

 
Full Story
 
Government, industry must work together to define cannabis promotions
  Government, industry must work together to define cannabis promotions
 

Chad Finkelstein

 
Full Story
 
Nearly 100 organizations have pre-qualified for expansion of retail cannabis sales, Manitoba says
  Nearly 100 organizations have pre-qualified for expansion of retail cannabis sales, Manitoba says
 

Steve Lambert

 
Full Story
 

Did you know? - We also have a Top Business Headlines: Evening Edition newsletter to help you catch up on the most important business news of the day. Sign up today.

 
 
More stories below advertisement
 
 
 
Cannabis marketplace
 
Nielsen partnering with Deloitte and U.S. software company to collect cannabis retail data in Canada
  Nielsen partnering with Deloitte and U.S. software company to collect cannabis retail data in Canada
 

Mark Rendell

 
Cannabis Industry Reporter
 
Full Story
 
Shopify and Brookfield Infrastructure to join TSX 60 index, two more pot stocks added to Composite
  Shopify and Brookfield Infrastructure to join TSX 60 index, two more pot stocks added to Composite
 

David Milstead

 
Institutional Investment Reporter
 
Full Story
 
 
Health, parenting and consumer
 
Dr. Charles Tator ‘reasonably hopeful’ cannabinoids could help with treatment of postconcussion issues
  Dr. Charles Tator ‘reasonably hopeful’ cannabinoids could help with treatment of postconcussion issues
 

Gregory Strong

One of Canada’s foremost brain-injury experts says he’s “reasonably hopeful” that there is potential for the medicinal value of cannabinoids to be combined with other treatments to help those affected by postconcussion issues.

 
Dr. Charles Tator, a neurosurgeon at Toronto Western Hospital’s Canadian Concussion Centre, weighed in on the subject after the NHL Alumni Association’s recent announcement that it would participate in a clinical-research partnership with NEEKA Health Canada and the Canopy Growth Corporation. The year-long study will test if cannabis-based therapies can help reduce the severity of neurological issues among former pro-hockey players and improve their quality of life.

 
“I think it’s worth a try,” Tator said. “I’m reasonably hopeful. But you know as a brain surgeon and concussion researcher, you have to be optimistic. You have to feel that somebody is going to get it right and we’re going to make a hit and there will be a breakthrough in this field. We really need better treatments.”

 
 
Full Story
 
 
Cannabis small business and retail
 
Canopy Growth acquires AgriNextUSA to boost U.S. hemp business
  Canopy Growth acquires AgriNextUSA to boost U.S. hemp business
 
Full Story
 
I want to be a master cannabis grower ... what will my salary be?
  I want to be a master cannabis grower ... what will my salary be?
 

Jared Lindzon

 
Full Story
 
For cannabis industry insiders, ROB Cannabis Professional is a separate premium newsletter sent daily and available for purchase.

 
The latest from Rob Cannabis Pro
 
European CBD sales to quintuple by 2023: Brightfield Group
Cannabis Professional content  European CBD sales to quintuple by 2023: Brightfield Group
 

Marcy Nicholson

  1. CBD sales in Europe forecast to surge to US$1.7-billion in 2023
  2. Germany to become Europe’s biggest CBD market in four years
  3. CBD has “exploded” as tobacco substitute in Europe, Brightfield says
Annual CBD sales in Europe will balloon by more than five times to reach nearly US$1.7-billion in 2023, with Germany taking the lead as the region’s biggest market while an influx of investments from Canadian licensed producers and other international players are expected to capitalize on the boom as regulations shift, Brightfield Group said in a report on Tuesday.

 
 
Full Story
 
 
 
Visit the ROB Cannabis Professional site to find out more about purchasing our premium subscription news service for cannabis industry insiders.
 
View More
 
 
About this newsletter
The Cannabis newsletter is sent once per week and is free. It will deliver the national news on legalized cannabis that is published on Globeandmail.com. The Globe’s reporters cover everything from the burgeoning cannabis industry to changing government policy and the societal impacts of legalization in Canada. Visit the Cannabis section on Globeandmail.com

ROB Cannabis Professional is a separate premium daily subscription news service for cannabis industry insiders.

If you have any feedback or questions about our Cannabis newsletter, please reach out to editor Michael Snider directly.

If you do not wish to receive this newsletter anymore, please refer to the unsubscribe link at the bottom of every email communication. Or, you can log into The Globe’s website and manage your preferences under Communication Settings.

Can't log in yet? Registration is free and allows you to read more articles for free. Here are tips to stay logged in.